Taconic Capital Advisors LP Seagen Inc. Transaction History

Taconic Capital Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.0 - $228.9 $0 - $156 Million	-682,000 Closed	0 $0
Q3 2023 Feb 14, 2024	SELL	$191.51 - $216.16 $31.7 Million - $35.8 Million	-165,500 Reduced 19.53%	682,000 $145 Million
Q2 2023 Feb 14, 2024	BUY	$187.64 - $206.25 $157 Million - $173 Million	837,500 Added 8375.0%	847,500 $163 Million
Q1 2023 Feb 14, 2024	BUY	$127.59 - $203.08 $1.28 Million - $2.03 Million	10,000 New	10,000 $2.02 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Taconic Capital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Taconic Capital Advisors LP with notifications on news.